Dipexium Pharmaceuticals Initiates Second Of Two Pivotal Phase 3 Clinical Trials Of Locilex® in Patients With Mild Infections Of Diabetic Foot Ulcers
July 21, 2014 at 08:08 AM EDT
Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced it has initiated patient enrollment in the second of two pivotal Phase 3 ...
